Jennison Associates’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-5,996
Closed -$1.08M 683
2021
Q4
$1.08M Sell
5,996
-134
-2% -$23.2K ﹤0.01% 603
2021
Q3
$910K Buy
+6,130
New +$939K ﹤0.01% 625
2020
Q2
Sell
-6,287
Closed -$412K 682
2020
Q1
$412K Buy
+6,287
New +$501K ﹤0.01% 593
2015
Q4
Sell
-16,383
Closed -$510K 719
2015
Q3
$510K Sell
16,383
-77
-0.5% -$2.76K ﹤0.01% 665
2015
Q2
$621K Sell
16,460
-770
-4% -$28.1K ﹤0.01% 700
2015
Q1
$605K Buy
17,230
+321
+2% +$10.6K ﹤0.01% 681
2014
Q4
$560K Sell
16,909
-110
-0.6% -$3.4K ﹤0.01% 689
2014
Q3
$465K Sell
17,019
-223
-1% -$6.11K ﹤0.01% 695
2014
Q2
$495K Buy
17,242
+13
+0.1% +$351 ﹤0.01% 688
2014
Q1
$493K Sell
17,229
-160
-0.9% -$4.38K ﹤0.01% 698
2013
Q4
$444K Sell
17,389
-213
-1% -$5.09K ﹤0.01% 679
2013
Q3
$417K Buy
17,602
+192
+1% +$4.28K ﹤0.01% 671
2013
Q2
$358K Buy
+17,410
New +$321K ﹤0.01% 651

Other funds holding OMCL

Jennison Associates's OMCL Position: Q1 2022 in Review

Jennison Associates sold out of Omnicell (OMCL) in Q1 2022, closing a stake of 5,996 shares — an estimated $1.08M sold.

Jennison Associates first reported a position in OMCL in Q2 2013 and held it in 13 quarters. The position peaked at $1.08M in Q4 2021. 396 funds tracked by Wall St. Rank hold OMCL as of Q1 2022.

  • Jennison Associates reported no remaining Omnicell position as of Q1 2022 after selling out during the quarter.
  • Jennison Associates sold 5,996 Omnicell shares in Q1 2022, an estimated $1.08M.
  • Jennison Associates first reported a position in Omnicell in Q2 2013 and held it in 13 quarters.
  • Jennison Associates's Omnicell position peaked at $1.08M in Q4 2021.
  • 396 funds tracked by Wall St. Rank held Omnicell as of Q1 2022.

Based on Jennison Associates's 13F filing for Q1 2022, filed 11 May 2022.